Search Tag: Mauro P. Avanzi

Executive Health Management

2023 21 Feb

Shoreline Biosciences, Inc., a biopharmaceutical company developing next-generation cellular immunotherapies based on induced pluripotent stem cells (iPSCs) utilizing its proprietary iPSC-derived natural killer (iNK) cell and macrophage (iMACs) platforms announced the appointment of  Mauro P. Avanzi , M.D., Ph.D. as Chief Medical Officer. Dr. Avanzi...Read more